RPTX – repare therapeutics inc. - common shares (US:NASDAQ)
Stock Stats
News
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition [Yahoo! Finance]
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition [Yahoo! Finance]
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
Form 8-K Repare Therapeutics Inc. For: Apr 24
Form ARS Repare Therapeutics Inc. For: Dec 31
Form DEFA14A Repare Therapeutics Inc.
Form DEF 14A Repare Therapeutics Inc. For: Jun 17
Form 4 Repare Therapeutics Inc. For: Mar 28 Filed by: Segal Lloyd Mitchell
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.